83-3899-52　Anti-Bevacizumab Antibody （AY9） （recommended for ADA assay） 100ug　BEB-Y9-100ug

特徴

• 背景
• A recombinant humanized monoclonal IgG1 antibody that binds to and inhibits the biologic activity of human vascular endothelial growth factor （VEGF）.
• Bevacizumab contains human framework regions and the complementarity-determining regions of a murine antibody that binds to VEGF.
• Bevacizumab is produced in a Chinese Hamster Ovary mammalian cell expression system in a nutrient medium containing the antibiotic gentamicin and has a molecular weight of approximately 149 kilodaltons.

仕様

• 容量：100ug
• Source：Anti-Bevacizumab Antibodies （recommended for ADA assay） antibody is produced from a hybridoma resulting from fusion of SP2/0 myeloma and B-lymphocytes obtained from a mouse immunized with Bevacizumab.
• Species Reactivity：Mouse
• Host：Hybridoma
• Tag：-
• Molecule：Bevacizumab
• Format：Powder
• Conjugate：Unconjugated
• Purity：95％
• Buffer：TriswithGlycine,ArginineandNaCl,pH7.5
• この商品は法規制を確認しておりません。（法規制によって販売できない場合もございます）

• 【試薬に関するお問合せ】
• アズワン株式会社 試薬・プロセス材料グループ
• TEL：06-6447-8641
• FAX：06-6447-8642
• E-mail：[email protected]